⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 20, 2024Frontiers in PharmacologyOpen Access

Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis

Jing Ling Xuping Yang Lulu Dong Yan Jiang Zou S Nan Hu

View Full Paper

Ask AI

Bookmark

Share

Abstract

Voriconazole is a broad-spectrum triazole antifungal agent. A number of studies have revealed that the impact of C-reactive protein (CRP) on voriconazole pharmacokinetics was associated with the

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ling et al. (2024) studied this question.

synapsesocial.com/papers/68e5b8abb6db6435875518c5 https://doi.org/10.3389/fphar.2024.1455721

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inflammation altered correlation between <i>CYP2C19</i> genotype and <scp>CYP2C19</scp> activity in patients receiving voriconazole2024 · 17 citations
2Discordant CYP2C19 genotype-phenotype relationship in voriconazole metabolism: impact of inflammation on drug exposure in a Chinese patientOriginal Research · 2026
3Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.Original Research · 2026 · 2 citations
4Pharmacogenomic Profiling of Voriconazole Enables Predicting Its Toxicity in Pediatric Leukemia and Hematopoietic Stem Cell Transplant Recipients—A Prospective Study From North IndiaCohort Study · 2026
5Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients2024 · 6 citations